title: [Expected limits (and possible consequences) of pathogen inactivation technology].
abstract: Pathogen reduction technology, now applicable to platelets and plasma, has limits that are already known, and potential or poorly defined other ones. We can distinguish limitations due to adverse events related to the technology itself or to recipient susceptibility, the limits of effectiveness depending on the target, the technology, organizational, economic and geographical limits.
authors.affiliation: Département d'études des agents transmissibles par le sang, institut national de la transfusion sanguine, Paris, France. jeanjacqueslefrere@orange.fr
authors.forename: J-J
authors.initials: JJ
authors.lastname: Lefrère
mesh_terms: D017848:Blood-Borne Pathogens; D006801:Humans; D017053:Infection Control / Q000379:methods*; D065227:Transfusion Reaction